{
    "uniprot_canonical_ac": "A0A0R4IJL2-1",
    "uniprot_id": [
        {
            "id": "A0A0R4IJL2_DANRE",
            "url": "https://www.uniprot.org/uniprot/A0A0R4IJL2_DANRE",
            "type": "external"
        }
    ],
    "mass": 49320.0,
    "length": 437,
    "protein_name": "Alpha-galactosidase",
    "gene_name": "naga",
    "organism": "Zebrafish",
    "refseq_name": "alpha-N-acetylgalactosaminidase precursor",
    "refseq_ac": [
        {
            "id": "NP_001032465",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001032465",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "naga; zgc:123333",
    "gene_names_refseq": "naga; zgc:123333",
    "protein_names_uniprotkb": "Alpha-galactosidase; 3.2.1.-",
    "protein_names_refseq": "alpha-N-acetylgalactosaminidase precursor",
    "tax_id": 7955,
    "disease": "Schindler disease type 1 (Disease Ontology:DOID:0112318); Kanzaki disease (Disease Ontology:DOID:0112319); Fabry disease (Disease Ontology:DOID:14499); neuroaxonal dystrophy (Disease Ontology:DOID:2367); angiokeratoma (Disease Ontology:DOID:479)",
    "pathway": " (dre:560778)",
    "pathway_count": 1,
    "publication_count": 5,
    "publication_id_list": "23570992;23594743;26469318;27189481;31299224",
    "function": "##Evidence-Data-START## Transcript exon combination :: BC108078.1, GDQH01003037.1 [ECO:0000332] RNAseq introns :: mixed sample support SAMEA3505371, SAMEA3505376 [ECO:0006172] ##Evidence-Data-END## VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from FO904962.2, EH453970.1, EH434772.1 and EH479732.1. On Jul 20, 2010 this sequence version replaced NP_001032465.1. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments., [RefSeq]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 5,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0004557 alpha-galactosidase activity",
    "go_cellular_component": "GO:0005737 cytoplasm;GO:0005764 lysosome",
    "go_biological_process": "GO:0006629 lipid metabolic process;GO:0009311 oligosaccharide metabolic process;GO:0016139 glycoside catabolic process",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0R4IJL2-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000000000000001.00000.000"
}